![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MALVERN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel, proprietary...
MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have...
MALVERN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | -0.0496 | -25.4881808839 | 0.1946 | 0.2345 | 0.1354 | 1134643 | 0.1778902 | CS |
26 | -0.0651 | -30.9852451214 | 0.2101 | 0.29 | 0.1314 | 1685704 | 0.19584397 | CS |
52 | -2.635 | -94.7841726619 | 2.78 | 3.09 | 0.0853 | 2959155 | 0.33253408 | CS |
156 | -9.195 | -98.4475374732 | 9.34 | 9.96 | 0.0853 | 2185858 | 1.83668662 | CS |
260 | -12.355 | -98.84 | 12.5 | 19.5 | 0.0853 | 1427587 | 2.12123817 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions